152 related articles for article (PubMed ID: 15942780)
21. Serum paraoxonase, arylesterase activity and oxidative status in patients with obstructive sleep apnea syndrome (OSAS).
Baysal E; Taysi S; Aksoy N; Uyar M; Celenk F; Karatas ZA; Tarakcioglu M; Bilinç H; Mumbuç S; Kanlikama M
Eur Rev Med Pharmacol Sci; 2012 Jun; 16(6):770-4. PubMed ID: 22913209
[TBL] [Abstract][Full Text] [Related]
22. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
Kwinta-Rybicka J; Wilkosz K; Wierzchowska-Słowiacze EK; Ogarek I; Moczulska A; Stec Z; Pełkowska A; Sancewicz-Pach K; Pietrzyk JA
Przegl Lek; 2006; 63 Suppl 3():44-8. PubMed ID: 16898486
[TBL] [Abstract][Full Text] [Related]
23. Urotensin-II level and its association with oxidative stress in early diabetic nephropathy.
Tabur S; Korkmaz H; Eren MA; Oğuz E; Sabuncu T; Aksoy N
J Diabetes Complications; 2015; 29(1):115-9. PubMed ID: 25179234
[TBL] [Abstract][Full Text] [Related]
24. Total oxidant, antioxidant, and paraoxonase levels in babies born to pre-eclamptic mothers.
Altunhan H; Annagür A; Kurban S; Ertuğrul S; Konak M; Örs R
J Obstet Gynaecol Res; 2013 May; 39(5):898-904. PubMed ID: 23551806
[TBL] [Abstract][Full Text] [Related]
25. Oxidative modification of low-density lipoprotein in relation to dyslipidemia and oxidant status in children with steroid sensitive nephrotic syndrome.
El-Melegy NT; Mohamed NA; Sayed MM
Pediatr Res; 2008 Apr; 63(4):404-9. PubMed ID: 18356747
[TBL] [Abstract][Full Text] [Related]
26. The influence of hemodialysis membrane permeability on serum paraoxonase-1 activity and oxidative status parameters.
Horoz M; Kiykim AA; Cimen B; Erdem A
Artif Organs; 2011 Oct; 35(10):923-9. PubMed ID: 21517907
[TBL] [Abstract][Full Text] [Related]
27. Lower serum paraoxonase-1 activity is related to higher serum amyloid a levels in metabolic syndrome.
Kappelle PJ; Bijzet J; Hazenberg BP; Dullaart RP
Arch Med Res; 2011 Apr; 42(3):219-25. PubMed ID: 21722818
[TBL] [Abstract][Full Text] [Related]
28. Plasma protein thiols and total antioxidant power in pediatric nephrotic syndrome.
Karthikeyan K; Sinha I; Prabhu K; Bhaskaranand N; Rao A
Nephron Clin Pract; 2008; 110(1):c10-4. PubMed ID: 18663332
[TBL] [Abstract][Full Text] [Related]
29. Gender-specific correlation between plasma myeloperoxidase levels and serum high-density lipoprotein-associated paraoxonase-1 levels in patients with stable and unstable coronary artery disease.
Yunoki K; Naruko T; Inaba M; Inoue T; Nakagawa M; Sugioka K; Ohsawa M; Iwasa Y; Komatsu R; Itoh A; Haze K; Yoshiyama M; Becker AE; Ueda M
Atherosclerosis; 2013 Dec; 231(2):308-14. PubMed ID: 24267244
[TBL] [Abstract][Full Text] [Related]
30. Oxidative stress and paraoxonase 1 activity predict contrast-induced nephropathy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Börekçi A; Gür M; Türkoğlu C; Çaylı M; Selek Ş; Kaypaklı O; Uçar H; Coşkun M; Şeker T; Koç M; Gökdeniz T; Gözükara MY
Angiology; 2015 Apr; 66(4):339-45. PubMed ID: 24830418
[TBL] [Abstract][Full Text] [Related]
31. Oxidative status and serum PON1 activity in beta-thalassemia minor.
Selek S; Aslan M; Horoz M; Gur M; Erel O
Clin Biochem; 2007 Mar; 40(5-6):287-91. PubMed ID: 17296173
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of children with steroid-sensitive nephrotic syndrome in terms of allergies.
Yılmaz D; Yenigün A; Sönmez F; Kurt Ömürlü İ
Ren Fail; 2015 Apr; 37(3):387-91. PubMed ID: 25598239
[TBL] [Abstract][Full Text] [Related]
33. Atorvastatin effect on high-density lipoprotein-associated paraoxonase activity and oxidative DNA damage.
Harangi M; Seres I; Varga Z; Emri G; Szilvássy Z; Paragh G; Remenyik E
Eur J Clin Pharmacol; 2004 Dec; 60(10):685-91. PubMed ID: 15490140
[TBL] [Abstract][Full Text] [Related]
34. Assessment of the serum paraoxonase activity and oxidant/antioxidant status in patients with recurrent aphthous stomatitis.
Bilgili SG; Ozkol H; Takci Z; Ozkol HU; Karadag AS; Aslan M
Int J Dermatol; 2013 Oct; 52(10):1259-64. PubMed ID: 23834345
[TBL] [Abstract][Full Text] [Related]
35. Paraoxonase activity in high-density lipoproteins: a comparison between healthy and obese females.
Ferretti G; Bacchetti T; Moroni C; Savino S; Liuzzi A; Balzola F; Bicchiega V
J Clin Endocrinol Metab; 2005 Mar; 90(3):1728-33. PubMed ID: 15613429
[TBL] [Abstract][Full Text] [Related]
36. Total antioxidant, total oxidant and serum paraoxonase levels according to lipid administration method in parenterally fed premature infants.
Konak M; Tarakci N; Altunhan H; Annagür A; Toker A; Örs R
J Matern Fetal Neonatal Med; 2017 Jul; 30(14):1734-1738. PubMed ID: 27583439
[TBL] [Abstract][Full Text] [Related]
37. Elevated blood plasma antioxidant status is favourable for achieving IVF/ICSI pregnancy.
Velthut A; Zilmer M; Zilmer K; Kaart T; Karro H; Salumets A
Reprod Biomed Online; 2013 Apr; 26(4):345-52. PubMed ID: 23415995
[TBL] [Abstract][Full Text] [Related]
38. Measurement of serum paraoxonase activity and MDA concentrations in patients suffering with oral squamous cell carcinoma.
Malik UU; Siddiqui IA; Hashim Z; Zarina S
Clin Chim Acta; 2014 Mar; 430():38-42. PubMed ID: 24389054
[TBL] [Abstract][Full Text] [Related]
39. Reduced total antioxidant level and increased oxidative stress in patients with deficit schizophrenia: a preliminary study.
Albayrak Y; Ünsal C; Beyazyüz M; Ünal A; Kuloğlu M
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():144-9. PubMed ID: 23657077
[TBL] [Abstract][Full Text] [Related]
40. Maternal-neonatal serum paraoxonase 1 activity in relation to the mode of delivery.
Vlachos GD; Bartzeliotou A; Schulpis KH; Partsinevelos GA; Lazaropoulou C; Papadima C; Papastamataki M; Antsaklis A; Papassotiriou I
Clin Biochem; 2006 Sep; 39(9):923-8. PubMed ID: 16790239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
